Role of kappa and delta opioid receptors in mediating morphine-induced antinociception in morphine-tolerant infant rats

Brain Research

Volumn 1142, Issue 1, 2007, Pages 28-36

  Stoller, Dawn C ^a   Sim Selley, Laura J ^a   Smith, Forrest L ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY MEDICAL CENTER   (United States)

^b HARDING UNIVERSITY   (United States)

Author keywords

Antinociception; Dependence; Morphine; Mu opioid receptor; Postnatal rat; Tolerance

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR ANTAGONIST; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; KAPPA OPIATE RECEPTOR ANTAGONIST; MORPHINE; MU OPIATE RECEPTOR; NALOXONE; NALTRINDOLE; NORBINALTORPHIMINE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONTINUOUS INFUSION; CONTROLLED STUDY; CROSS TOLERANCE; DOSE RESPONSE; DRUG EFFICACY; DRUG RECEPTOR BINDING; FEMALE; MORPHINE TOLERANCE; NONHUMAN; OSMOTIC MINIPUMP; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; TEMPERATURE DEPENDENCE;

ANALGESICS, NON-NARCOTIC; ANIMALS; ANIMALS, NEWBORN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DELIVERY SYSTEMS; DRUG INTERACTIONS; DRUG TOLERANCE; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; FEMALE; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; NARCOTICS; PAIN MEASUREMENT; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; TRITIUM;

RATTUS;

EID: 33947114794     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.01.028     Document Type: Article

References (40)

1. Alberti I., Fernandez B., Alguacil L.F., Aguilar A., Caamano M., Romero E.M., and Viveros M.P. Preweanling naltrindole administration differentially affects clonidine induced antinociception and plasma adrenaline levels in male and female neonatal rats. Br. J. Pharmacol. 128 (1999) 953-960
2. Barr G.A., and Wang S. Tolerance and withdrawal to chronic morphine treatment in the week-old rat pup. Eur. J. Pharmacol. 215 (1992) 35-42
3. Bliss C. Statistics in Biology (1967), McGraw Hill, New York 439 pp.
4. Brady L.S., Herkenham M., Long J.B., and Rothman R.B. Chronic morphine increases mu-opiate receptor binding in rat brain: a quantitative autoradiographic study. Brain Res. 477 (1989) 382-386
5. Corbett A.D., Patterson S.J., and Kosterlitz H.W. Selectivity of Ligands for Opioid Receptors (1993), Springer-Verlag, Berlin
6. Dalton G.D., Smith F.L., Smith P.A., and Dewey W.L. Protein kinase A activity is increased in mouse lumbar spinal cord but not brain following morphine antinociceptive tolerance for 15 days. Pharmacol. Res. 52 (2005) 204-210
7. Deng H.B., Yu Y., Wang H., Guang W., and Wang J.B. Agonist-induced mu opioid receptor phosphorylation and functional desensitization in rat thalamus. Brain Res. 898 (2001) 204-214
8. Fernandez B., Antelo M.T., Kitchen I., and Viveros M.P. Effects of neonatal naltrindole treatment on antinociceptive and behavioral responses to mu and kappa agonists in rats. Pharmacol. Biochem. Behav. 62 (1999) 145-149
9. Granados-Soto V., Kalcheva I., Hua X., Newton A., and Yaksh T.L. Spinal PKC activity and expression: role in tolerance produced by continuous spinal morphine infusion. Pain 85 (2000) 395-404
10. Kim Y.I., Na H.S., Han J.S., and Hong S.K. Critical role of the capsaicin-sensitive nerve fibers in the development of the causalgic symptoms produced by transecting some but not all of the nerves innervating the rat tail. J. Neurosci. 15 (1995) 4133-4139
11. Kitchen I., and Pinker S.R. Antagonism of swim-stress-induced antinociception by the delta-opioid receptor antagonist naltrindole in adult and young rats. Br. J. Pharmacol. 100 (1990) 685-688
12. Kruzich P.J., Chen A.C., Unterwald E.M., and Kreek M.J. Subject-regulated dosing alters morphine self-administration behavior and morphine-stimulated [35S]GTPgammaS binding. Synapse 47 (2003) 243-249
13. Nemmani K.V., and Mogil J.S. Serotonin-GABA interactions in the modulation of mu- and kappa-opioid analgesia. Neuropharmacology 44 (2003) 304-310
14. O'Callaghan J.P., and Holtzman S.G. Prenatal administration of morphine to the rat: tolerance to the analgesic effect of morphine in the offspring. J. Pharmacol. Exp. Ther. 197 (1976) 533-544
15. Paronis C.A., and Holtzman S.G. Development of tolerance to the analgesic activity of mu agonists after continuous infusion of morphine, meperidine or fentanyl in rats. J. Pharmacol. Exp. Ther. 262 (1992) 1-9
16. Petrillo P., Tavani A., Verotta D., Robson L.E., and Kosterlitz H.W. Differential postnatal development of mu-, delta- and kappa-opioid binding sites in rat brain. Brain Res. 428 (1987) 53-58
17. Petruzzi R., Ferraro T.N., Kurschner V.C., Golden G.T., and Berrettini W.H. The effects of repeated morphine exposure on mu opioid receptor number and affinity in C57BL/6J and DBA/2J mice. Life Sci. 61 (1997) 2057-2064
18. Polastron J., Meunier J.C., and Jauzac P. Chronic morphine induces tolerance and desensitization of mu-opioid receptor but not down-regulation in rabbit. Eur. J. Pharmacol. 266 (1994) 139-146
19. Przewlocki R., and Przewlocka B. Opioids in chronic pain. Eur. J. Pharmacol. 429 (2001) 79-91
20. Shen J., Benedict Gomes A., Gallagher A., Stafford K., and Yoburn B.C. Role of cAMP-dependent protein kinase (PKA) in opioid agonist-induced mu-opioid receptor downregulation and tolerance in mice. Synapse 38 (2000) 322-327
21. Sim-Selley L.J., Selley D.E., Vogt L.J., Childers S.R., and Martin T.J. Chronic heroin self-administration desensitizes mu opioid receptor-activated G-proteins in specific regions of rat brain. J. Neurosci. 20 (2000) 4555-4562
22. Sim-Selley L.J., Xiao R., and Childers S.R. Anatomical distribution of sodium-dependent [(3)H]naloxone binding sites in rat brain. Synapse 35 (2000) 256-264
23. Sim L.J., Selley D.E., Dworkin S.I., and Childers S.R. Effects of chronic morphine administration on mu opioid receptor-stimulated [35S]GTPgammaS autoradiography in rat brain. J. Neurosci. 16 (1996) 2684-2692
24. Smith F.L., Dombrowski D.S., and Dewey W.L. Involvement of intracellular calcium in morphine tolerance in mice. Pharmacol. Biochem. Behav. 62 (1999) 381-388
25. Smith F.L., Lohmann A.B., and Dewey W.L. Involvement of phospholipid signal transduction pathways in morphine tolerance in mice. Br. J. Pharmacol. 128 (1999) 220-226
26. Stafford K., Gomes A.B., Shen J., and Yoburn B.C. mu-Opioid receptor downregulation contributes to opioid tolerance in vivo. Pharmacol. Biochem. Behav. 69 (2001) 233-237
27. Stoller D.C., and Smith F.L. Buprenorphine blocks withdrawal in morphine-dependent rat pups. Paediatr. Anaesth. 14 (2004) 642-649
28. Stoller D.C., Thornton S.R., and Smith F.L. Loss of antinociceptive efficacy in rat pups infused with morphine from osmotic minipumps. Pharmacology 66 (2002) 11-18
29. Suzuki T., Mori T., Tsuji M., Misawa M., and Nagase H. The role of delta-opioid receptors in the discriminative stimulus properties of a low dose of methamphetamine. Eur. J. Pharmacol. 331 (1997) 1-8
30. Takemori A.E., Ho B.Y., Naeseth J.S., and Portoghese P.S. Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays. J. Pharmacol. Exp. Ther. 246 (1988) 255-258
31. Tempel A., and Espinoza K. Morphine-induced downregulation of mu-opioid receptors and peptide synthesis in neonatal rat brain. Ann. N. Y. Acad. Sci. 654 (1992) 529-530
32. Thornton S.R., and Smith F.L. Long-term alterations in opiate antinociception resulting from infant fentanyl tolerance and dependence. Eur. J. Pharmacol. 363 (1998) 113-119
33. Thornton S.R., Wang A.F., and Smith F.L. Characterization of neonatal rat morphine tolerance and dependence. Eur. J. Pharmacol. 340 (1997) 161-167
34. Welch S.P., Smith F.L., and Dewey W.L. Morphine tolerance-induced modulation of [3H]glyburide binding to mouse brain and spinal cord. Drug Alcohol Depend. 45 (1997) 47-53
35. Wilson S.G., Smith S.B., Chesler E.J., Melton K.A., Haas J.J., Mitton B., Strasburg K., Hubert L., Rodriguez-Zas S.L., and Mogil J.S. The heritability of antinociception: common pharmacogenetic mediation of five neurochemically distinct analgesics. J. Pharmacol. Exp. Ther. 304 (2003) 547-559
36. Windh R.T., Little P.J., and Kuhn C.M. The ontogeny of mu opiate tolerance and dependence in the rat: antinociceptive and biochemical studies. J. Pharmacol. Exp.Ther. 273 (1995) 1361-1374
37. Yamada H., Shimoyama N., Sora I., Uhl G.R., Fukuda Y., Moriya H., and Shimoyama M. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors. Brain Res. 1083 (2006) 61-69
38. Yashpal K., Pitcher G.M., Parent A., Quirion R., and Coderre T.J. Noxious thermal and chemical stimulation induce increases in 3H-phorbol 12,13-dibutyrate binding in spinal cord dorsal horn as well as persistent pain and hyperalgesia, which is reduced by inhibition of protein kinase C. J. Neurosci. 15 (1995) 3263-3272
39. Yi D.K., and Barr G.A. The induction of Fos-like immunoreactivity by noxious thermal, mechanical and chemical stimuli in the lumbar spinal cord of infant rats. Pain 60 (1995) 257-265
40. Yoburn B.C., Billings B., and Duttaroy A. Opioid receptor regulation in mice. J. Pharmacol. Exp. Ther. 265 (1993) 314-320